COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
10/04/2018
REGULATED INFORMATION GHENT, Belgium, 10 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
10/04/2018
REGULATED INFORMATION GHENT, Belgium, 10 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Biocartis Group NV: Invitation to Annual Shareholders' Meeting
10/04/2018
PRESS RELEASE : REGULATED INFORMATION10 April 2018, 07:00 CEST Invitation to Annual Shareholders' Meeting Biocartis to propose new board composition Mechelen, Belgium, 10 April 2018 - Biocartis Group NV (the 'Company' [...]
Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology
10/04/2018
Study Evaluated the Safety of Tazemetostat and Established the Recommended Phase 2 Dose; Anti-Tumor Activity Observed in Multiple Tumor Types CAMBRIDGE, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: [...]
Emblem Announces Director Resignation
09/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSX-V: EMC ) (TSX-V:EMC.WT) (“Emblem” or the “Company ” ) , [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/04/2018
SOUTH SAN FRANCISCO, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
MPI - Notice to convene ordinary annual general meeting
09/04/2018
Indkaldelse til ORDINÆR Generalforsamling Notice to convene ORDINARY ANNUAL General Meeting Der indkaldes herved til ORDINÆR generalforsamling i Medical Prognosis Institute A/S ("Selskabet"): Notice is hereby given that [...]
MannKind Announces Completion of Previously Announced $28.0 Million Registered Direct Offering
09/04/2018
WESTLAKE VILLAGE, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) today announced the completion of its previously announced registered direct offering of 14,000,000 shares of common [...]
Medtronic to Unveil Additional Clinical Data on HVAD® System at ISHLT 2018
09/04/2018
Data on Implant Approach, Blood Pressure Management, Length of Stay, and Quality of Life to be Featured During Congress. DUBLIN - April 9, 2018 - Medtronic plc (NYSE: MDT) today announced a preview of notable clinical [...]
Allscripts to release first-quarter 2018 financial results May 3
09/04/2018
CHICAGO, April 09, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq: MDRX ) will report its financial results for the three months ended March 31, 2018, after the close of stock market hours on [...]
Rankin County Hospital District Launches Cerner Electronic Health Record
09/04/2018
RANKIN, Texas, April 09, 2018 (GLOBE NEWSWIRE) -- Rankin County Hospital District (RCHD) has implemented an integrated electronic health record (EHR) with Cerner, a global leader in health care technology, to support [...]
Caladrius Biosciences to Participate at Upcoming April Conferences
09/04/2018
BASKING RIDGE, N.J., April 09, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Scythian Poised to Enter Argentina Cannabis Market
09/04/2018
ABP S.A., Sets Milestone Receiving Argentina’s First & Only Cannabis License Scythian Sets Pace for Argentina Cannabis Market Through Aphria Partnership and Exclusive Agreements With Country’s Largest Pediatric [...]
Tivity Health CEO Donato Tramuto Named Chairman of Robert F. Kennedy Human Rights Leadership Council
09/04/2018
Tramuto to lead national initiative on workplace dignity FRANKLIN, Tenn. and BOSTON, April 09, 2018 (GLOBE NEWSWIRE) -- Donato Tramuto has been named Chairman of the Leadership Council of Robert F. Kennedy Human Rights [...]
SuperSonic Imagine Showcasing Aixplorer Ultimate During the International Liver Congress (ILC) 2018
09/04/2018
SuperSonic Imagine will demonstrate the benefits of its Aixplorer Ultimate ultrasound system for the non-invasive assessment of chronic liver diseases AIX-EN-PROVENCE, France, April 09, 2018 (GLOBE NEWSWIRE) -- [...]
BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction
09/04/2018
ANAHEIM, CA, April 09, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
09/04/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 09 avril 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Ossur Hf : Transactions in relation to share buyback program
09/04/2018
Announcement no. 27/2018 Reykjavik, 09 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Innovation Pharmaceuticals Phase 2 Oral Mucositis Trial Additional Data Show Brilacidin-OM Demonstrated A Significant Reduction in the Incidence of Severe Oral Mucositis in Patients with Head and Neck Cancer (HNC) Receiving Aggressive Chemotherapy Regimen
09/04/2018
BEVERLY, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report further data analysis from its successfully [...]

Pages